Abstract

LCAT is an enzyme responsible for the formation of cholesteryl esters from unesterified cholesterol (UC) and phospholipid (PL) molecules in HDL particles. However, it is poorly understood how LCAT interacts with lipoproteins and how apoA-I activates it. Here we have studied the interactions between LCAT and lipids through molecular simulations. In addition, we studied the binding of LCAT to apoA-I-derived peptides, and their effect on LCAT lipid association-utilizing experiments. Results show that LCAT anchors itself to lipoprotein surfaces by utilizing nonpolar amino acids located in the membrane-binding domain and the active site tunnel opening. Meanwhile, the membrane-anchoring hydrophobic amino acids attract cholesterol molecules next to them. The results also highlight the role of the lid-loop in the lipid binding and conformation of LCAT with respect to the lipid surface. The apoA-I-derived peptides from the LCAT-activating region bind to LCAT and promote its lipid surface interactions, although some of these peptides do not bind lipids individually. The transfer free-energy of PL from the lipid bilayer into the active site is consistent with the activation energy of LCAT. Furthermore, the entry of UC molecules into the active site becomes highly favorable by the acylation of SER181.

Highlights

  • LCAT is an enzyme responsible for the formation of cholesteryl esters from unesterified cholesterol (UC) and phospholipid (PL) molecules in HDL particles

  • We have studied the interactions of LCAT with lipid surfaces and apoA-I-derived peptides to gain novel information regarding the molecular mechanism behind the LCAT-catalyzed CHOL esterification taking place at the surface of lipoprotein particles

  • The simulation results showed that the lid region of LCAT forms a coil secondary structure accompanied by relatively high residual fluctuations when compared with the other structural parts of LCAT

Read more

Summary

Introduction

LCAT is an enzyme responsible for the formation of cholesteryl esters from unesterified cholesterol (UC) and phospholipid (PL) molecules in HDL particles. It is poorly understood how LCAT interacts with lipoproteins and how apoA-I activates it. Low HDL cholesterol (HDL-C) and elevated triglyceride levels are attributed as the two key contributors to the high residual CHD risk [2]. A high HDL-C concentration in blood has been regarded as a preventive measure reflecting the ability of HDL particles to transport CHOL from the peripheral tissues back to the liver, including the mainly LDLderived CHOL from the arterial walls This process is termed reverse CHOL transport (RCT) [5, 6].

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.